** Surgery Partners' shares SGRY.O rise 7.3% to $30.81 in
afternoon trade
** Reports Q2 adjusted EPS of 21 cents vs estimate of 20
cents - LSEG data
** Q2 rev. of $762.1 mln beats estimate of $735.6 mln
** Raises 2024 revenue forecast to be greater than
$3.075 billion vs at least $3.05 billion given in May
** 10 of 12 brokerages rate the stock "buy" or higher, 2
"hold"; their median PT is $38 - LSEG data
** Including session's move, stock down 3.7% YTD
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))